{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:58:54Z","timestamp":1791187134884,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2005,4,21]],"date-time":"2005-04-21T00:00:00Z","timestamp":1114041600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1007\/s00125-005-1732-4","type":"journal-article","created":{"date-parts":[[2005,4,20]],"date-time":"2005-04-20T03:52:20Z","timestamp":1113969140000},"page":"838-848","source":"Crossref","is-referenced-by-count":183,"title":["Effect of pramlintide on satiety and food intake in obese subjects and subjects with type 2 diabetes"],"prefix":"10.1007","volume":"48","author":[{"given":"I.","family":"Chapman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Doran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Feinle-Bisset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Wishart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Strobel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Lush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Weyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Horowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,4,21]]},"reference":[{"key":"1732_CR1","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/00075197-200307000-00002","volume":"6","author":"M Druce","year":"2003","unstructured":"Druce M, Bloom SR (2003) Central regulators of food intake. Curr Opin Clin Nutr Metab Care 6:361\u2013367","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"1732_CR2","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1210\/jc.2004-0189","volume":"89","author":"K Wynne","year":"2004","unstructured":"Wynne K, Stanley S, Bloom S (2004) The gut and regulation of body weight. J Clin Endocrinol Metab 89:2576\u20132582","journal-title":"J Clin Endocrinol Metab"},{"key":"1732_CR3","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1210\/en.2004-0089","volume":"145","author":"MR Druce","year":"2004","unstructured":"Druce MR, Small CJ, Bloom SR (2004) Minireview: gut peptides regulating satiety. Endocrinology 145:2660\u20132665","journal-title":"Endocrinology"},{"key":"1732_CR4","doi-asserted-by":"crossref","first-page":"G693","DOI":"10.1152\/ajpgi.00536.2003","volume":"286","author":"S Stanley","year":"2004","unstructured":"Stanley S, Wynne K, Bloom S (2004) Gastrointestinal satiety signals: III. Glucagon-like peptide 1, oxyntomodulin, peptide YY, and pancreatic polypeptide. Am J Physiol Gastrointest Liver Physiol 286:G693\u2013G697","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1732_CR5","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2174\/1389450043490541","volume":"5","author":"JC Halford","year":"2004","unstructured":"Halford JC, Cooper GD, Dovey TM (2004) The pharmacology of human appetite expression. Curr Drug Targets 5:221\u2013240","journal-title":"Curr Drug Targets"},{"key":"1732_CR6","doi-asserted-by":"crossref","first-page":"5992","DOI":"10.1210\/jcem.86.12.8111","volume":"86","author":"AM Wren","year":"2001","unstructured":"Wren AM, Seal LJ, Cohen MA et al (2001) Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 86:5992","journal-title":"J Clin Endocrinol Metab"},{"key":"1732_CR7","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/0031-9384(82)90230-X","volume":"29","author":"X Pi-Sunyer","year":"1982","unstructured":"Pi-Sunyer X, Kissileff HR, Thornton J, Smith GP (1982) C-terminal octapeptide of cholecystokinin decreases food intake in obese men. Physiol Behav 29:627\u2013630","journal-title":"Physiol Behav"},{"key":"1732_CR8","doi-asserted-by":"crossref","first-page":"G98","DOI":"10.1152\/ajpgi.2000.278.1.G98","volume":"278","author":"CK Rayner","year":"2000","unstructured":"Rayner CK, Park HS, Doran SM, Chapman IM, Horowitz M (2000) Effects of cholecystokinin on appetite and pyloric motility during physiological hyperglycemia. Am J Physiol Gastrointest Liver Physiol 278:G98\u2013G104","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1732_CR9","first-page":"R1541","volume":"276","author":"JP Gutzwiller","year":"1999","unstructured":"Gutzwiller JP, Drewe J, Goke B et al (1999) Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2. Am J Physiol 276:R1541\u2013R1544","journal-title":"Am J Physiol"},{"key":"1732_CR10","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/sj.ijo.0800818","volume":"23","author":"E Naslund","year":"1999","unstructured":"Naslund E, Barkeling B, King N et al (1999) Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men. Int J Obes 23:304\u2013311","journal-title":"Int J Obes"},{"key":"1732_CR11","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1172\/JCI990","volume":"101","author":"A Flint","year":"1998","unstructured":"Flint A, Raben A, Astrup A, Holst JJ (1998) Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. J Clin Invest 101:515\u2013520","journal-title":"J Clin Invest"},{"key":"1732_CR12","doi-asserted-by":"crossref","first-page":"4696","DOI":"10.1210\/jc.2003-030421","volume":"88","author":"MA Cohen","year":"2003","unstructured":"Cohen MA, Ellis SM, Le Roux CW et al (2003) Oxyntomodulin suppresses appetite and reduces food intake in humans. J Clin Endocrinol Metab 88:4696\u20134701","journal-title":"J Clin Endocrinol Metab"},{"key":"1732_CR13","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nature00887","volume":"418","author":"RL Batterham","year":"2002","unstructured":"Batterham RL, Cowley MA, Small CJ et al (2002) Gut hormone PYY(3\u201336) physiologically inhibits food intake. Nature 418:650\u2013654","journal-title":"Nature"},{"key":"1732_CR14","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1056\/NEJMoa030204","volume":"349","author":"RL Batterham","year":"2003","unstructured":"Batterham RL, Cohen MA, Ellis SM et al (2003) Inhibition of food intake in obese subjects by peptide YY3\u201336. N Engl J Med 349:941\u2013948","journal-title":"N Engl J Med"},{"key":"1732_CR15","doi-asserted-by":"crossref","first-page":"R975","DOI":"10.1152\/ajpcell.1992.262.4.C975","volume":"262","author":"N Geary","year":"1992","unstructured":"Geary N, Kissileff HR, Pi-Sunyer FX, Hinton V. (1992) Individual, but not simultaneous, glucagon and cholecystokinin infusions inhibit feeding in men. Am J Physiol 262:R975\u2013R980","journal-title":"Am J Physiol"},{"key":"1732_CR16","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1210\/jc.2003-030630","volume":"88","author":"RL Batterham","year":"2003","unstructured":"Batterham RL, Le Roux CW, Cohen MA et al (2003) Pancreatic polypeptide reduces appetite and food intake in humans. J Clin Endocrinol Metab 88:3989\u20133992","journal-title":"J Clin Endocrinol Metab"},{"key":"1732_CR17","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000126831","volume":"61","author":"RJ Lieverse","year":"1995","unstructured":"Lieverse RJ, Jansen JB, Masclee AM, Lamers CB (1995) Effects of somatostatin on human satiety. Neuroendocrinology 61:112\u2013116","journal-title":"Neuroendocrinology"},{"key":"1732_CR18","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/00060793-199708000-00006","volume":"4","author":"AA Young","year":"1997","unstructured":"Young AA (1997) Amylin\u2019s physiology and its role in diabetes. Curr Opin Endocrinol Diabetes 4:282\u2013290","journal-title":"Curr Opin Endocrinol Diabetes"},{"key":"1732_CR19","first-page":"493","volume":"44","author":"K Beaumont","year":"1993","unstructured":"Beaumont K, Kenney MA, Young AA, Rink TJ (1993) High affinity amylin binding sites in rat brain. Mol Pharmacol 44:493\u2013497","journal-title":"Mol Pharmacol"},{"key":"1732_CR20","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/0306-4522(94)90388-3","volume":"62","author":"PM Sexton","year":"1994","unstructured":"Sexton PM, Paxinos G, Kenney MA, Wookey PJ, Beaumont K (1994) In vitro autoradiographic localization of amylin binding sites in rat brain. Neuroscience 62:553\u2013567","journal-title":"Neuroscience"},{"key":"1732_CR21","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1210\/endo.140.6.6930","volume":"140","author":"R Muff","year":"1999","unstructured":"Muff R, Buhlmann N, Fischer JA, Born W (1999) An amylin receptor is revealed following co-transfection of a calcitonin receptor with receptor activity modifying proteins-1 or -3. Endocrinology 140:2924\u20132927","journal-title":"Endocrinology"},{"key":"1732_CR22","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1210\/endo.141.2.7378","volume":"141","author":"PA Rushing","year":"2000","unstructured":"Rushing PA, Hagan MM, Seeley RJ, Lutz TA, Woods SC (2000) Amylin: a novel action in the brain to reduce body weight. Endocrinology 141:850\u2013853","journal-title":"Endocrinology"},{"key":"1732_CR23","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/sj.ijo.0801664","volume":"25","author":"TA Lutz","year":"2001","unstructured":"Lutz TA, Mollet A, Rushing PA, Riediger T, Scharrer E (2001) The anorectic effect of a chronic peripheral infusion of amylin is abolished in area postrema\/nucleus of the solitary tract (AP\/NTS) lesioned rats. Int J Obes Relat Metab Disord 25:1005\u20131011","journal-title":"Int J Obes Relat Metab Disord"},{"key":"1732_CR24","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1055\/s-2007-978590","volume":"32","author":"PA Rushing","year":"2000","unstructured":"Rushing PA, Lutz TA, Seeley RJ, Woods SC (2000) Amylin and insulin interact to reduce food intake in rats. Horm Metab Res 32:62\u201366","journal-title":"Horm Metab Res"},{"issue":"Suppl 1","key":"1732_CR25","first-page":"A389","volume":"52","author":"C Mack","year":"2003","unstructured":"Mack C, Hoyt J, Moore C, Jodka C, Sams-Dodd F (2003) Sustained reduction in food intake and body weight in high fat-fed rats during 28-day amylin infusion. Diabetes 52[Suppl 1]:A389 (Abstract 1690-P)","journal-title":"Diabetes"},{"key":"1732_CR26","doi-asserted-by":"crossref","first-page":"5035","DOI":"10.1210\/endo.142.11.8593","volume":"142","author":"PA Rushing","year":"2001","unstructured":"Rushing PA, Hagan MM, Seeley RJ et al (2001) Inhibition of central amylin signaling increases food intake and body adiposity in rats. Endocrinology 142:5035\u20135038","journal-title":"Endocrinology"},{"key":"1732_CR27","doi-asserted-by":"crossref","first-page":"R568","DOI":"10.1152\/ajpregu.00213.2004","volume":"287","author":"RD Reidelberger","year":"2004","unstructured":"Reidelberger RD, Haver AC, Arnelo U, Smith DD, Schaffert CS, Permert J (2004) Amylin receptor blockade stimulates food intake in rats. Am J Physiol 287:R568\u2013R574","journal-title":"Am J Physiol"},{"key":"1732_CR28","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.2174\/1381612013397357","volume":"7","author":"C Weyer","year":"2001","unstructured":"Weyer C, Maggs DG, Young AA, Kolterman OG (2001) Amylin replacement with pramlintide as an adjunct to insulin therapy in type 1 and type 2 diabetes mellitus: a physiological approach toward improved metabolic control. Curr Pharm Des 7:1353\u20131373","journal-title":"Curr Pharm Des"},{"key":"1732_CR29","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1089\/15209150260007390","volume":"4","author":"SV Edelman","year":"2002","unstructured":"Edelman SV, Weyer C (2002) Unresolved challenges with insulin therapy in type 1 and type 2 diabetes: potential benefit of replacing amylin, a second \u03b2-cell hormone. Diabetes Technol Ther 4:175\u2013189","journal-title":"Diabetes Technol Ther"},{"key":"1732_CR30","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/dmrr.419","volume":"20","author":"DG Maggs","year":"2004","unstructured":"Maggs DG, Fineman MS, Kornstein J et al (2004) Pramlintide reduces postprandial glucose excursions when added to insulin lispro in subjects with type 2 diabetes: a dose timing study. Diabetes Metab Res Rev 20:55\u201360","journal-title":"Diabetes Metab Res Rev"},{"key":"1732_CR31","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1055\/s-2002-34790","volume":"34","author":"M Fineman","year":"2002","unstructured":"Fineman M, Weyer C, Maggs DG, Strobel S, Kolterman OG (2002) The human amylin analog, pramlintide, reduces postprandial hyperglucagonemia in patients with type 2 diabetes mellitus. Horm Metab Res 34:504\u2013508","journal-title":"Horm Metab Res"},{"key":"1732_CR32","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1046\/j.1365-2982.2002.00311.x","volume":"14","author":"A Vella","year":"2002","unstructured":"Vella A, Lee JS, Camilleri M et al (2002) Effects of pramlintide, an amylin analogue, on gastric emptying in type 1 and 2 diabetes mellitus. Neurogastroenterol Motil 14:123\u2013131","journal-title":"Neurogastroenterol Motil"},{"key":"1732_CR33","doi-asserted-by":"crossref","first-page":"724","DOI":"10.2337\/diacare.25.4.724","volume":"25","author":"FW Whitehouse","year":"2002","unstructured":"Whitehouse FW, Kruger D, Fineman MS et al (2002) A randomized study and open label extension evaluating the long-term efficacy of pramlintide as an adjunct to insulin therapy in type 1 diabetes. Diabetes Care 25:724\u2013730","journal-title":"Diabetes Care"},{"key":"1732_CR34","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1089\/15209150252924094","volume":"4","author":"RE Ratner","year":"2002","unstructured":"Ratner RE, Want LL, Fineman MS et al (2002) Adjunctive therapy with the amylin analogue pramlintide leads to a combined improvement in glycemic and weight control in insulin-treated patients with type 2 diabetes. Diabetes Technol Ther 4:51\u201361","journal-title":"Diabetes Technol Ther"},{"key":"1732_CR35","doi-asserted-by":"crossref","first-page":"784","DOI":"10.2337\/diacare.26.3.784","volume":"26","author":"PA Hollander","year":"2003","unstructured":"Hollander PA, Levy P, Fineman MS et al (2003) Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes mellitus: a one year randomized controlled trial. Diabetes Care 26:784\u2013790","journal-title":"Diabetes Care"},{"key":"1732_CR36","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/oby.2004.76","volume":"12","author":"P Hollander","year":"2004","unstructured":"Hollander P, Fineman MS, Ruggles JA et al (2004) Effect of pramlintide on weight in overweight and obese insulin-treated type 2 diabetes patients. Obes Res 12:661\u2013668","journal-title":"Obes Res"},{"key":"1732_CR37","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/ajcn\/60.6.895","volume":"60","author":"MC Martini","year":"1994","unstructured":"Martini MC, Lampe JW, Slavin JL, Kurzer MS (1994) Effect of the menstrual cycle on energy and nutrient intake. Am J Clin Nutr 60:895\u2013899","journal-title":"Am J Clin Nutr"},{"key":"1732_CR38","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0022-3999(85)90010-8","volume":"29","author":"AJ Stunkard","year":"1985","unstructured":"Stunkard AJ, Messick S (1985) The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger. J Psychosom Res 29:71\u201383","journal-title":"J Psychosom Res"},{"key":"1732_CR39","volume-title":"Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. WHO Technical Report Series, 854","author":"World Health Organization","year":"1995","unstructured":"World Health Organization (1995) Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. WHO Technical Report Series, 854. World Health Organization, Geneva"},{"key":"1732_CR40","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0195-6663(89)90011-1","volume":"13","author":"CP Sepple","year":"1989","unstructured":"Sepple CP, Read NW (1989) Gastrointestinal correlates of the development of hunger in man. Appetite 13:183\u2013191","journal-title":"Appetite"},{"key":"1732_CR41","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1006\/appe.1997.0096","volume":"29","author":"SM Green","year":"1997","unstructured":"Green SM, Delargy HJ, Joanes D, Blundell JE (1997) A satiety quotient: a formulation to assess the satiating effect of food. Appetite 29:291\u2013304","journal-title":"Appetite"},{"key":"1732_CR42","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1017\/S0007114598001615","volume":"80","author":"A Santangelo","year":"1998","unstructured":"Santangelo A, Peracchi M, Conte D, Fraquelli M, Porrini M (1998) Physical state of meal affects gastric emptying, cholecystokinin release and satiety. Br J Nutr 80:521\u2013527","journal-title":"Br J Nutr"},{"key":"1732_CR43","doi-asserted-by":"crossref","first-page":"5830","DOI":"10.1210\/jcem.86.12.8107","volume":"86","author":"CG MacIntosh","year":"2001","unstructured":"MacIntosh CG, Morley JE, Wishart J et al (2001) Effect of exogenous cholecystokinin (CCK)-8 on food intake and plasma CCK, leptin, and insulin concentrations in older and young adults: evidence for increased CCK activity as a cause of the anorexia of aging. J Clin Endocrinol Metab 86:5830\u20135837","journal-title":"J Clin Endocrinol Metab"},{"key":"1732_CR44","unstructured":"Linco Research. Available at: http:\/\/www.lincoresearch.com, last accessed in October 2004"},{"key":"1732_CR45","first-page":"80","volume":"53","author":"Centers for Disease Control and Prevention","year":"2004","unstructured":"Centers for Disease Control and Prevention (2004) Trends in intake of energy and macronutrients\u2014United States, 1971\u20132000. MMWR Morb Mortal Wkly Rep 53:80\u201382","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1732_CR46","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/0031-9384(95)02067-5","volume":"58","author":"TA Lutz","year":"1995","unstructured":"Lutz TA, Geary N, Szabady MM, Del Prete E, Scharrer E (1995) Amylin decreases meal size in rats. Physiol Behav 58:1197\u20131202","journal-title":"Physiol Behav"},{"key":"1732_CR47","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1210\/endo.140.4.6643","volume":"140","author":"AS Rocca","year":"1999","unstructured":"Rocca AS, Brubaker PL (1999) Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion. Endocrinology 140:1687\u20131694","journal-title":"Endocrinology"},{"key":"1732_CR48","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0196-9781(94)00203-I","volume":"16","author":"TA Lutz","year":"1995","unstructured":"Lutz TA, Del Prete E, Scharrer E (1995) Subdiaphragmatic vagotomy does not influence the anorectic effect of amylin. Peptides 16:457\u2013462","journal-title":"Peptides"},{"key":"1732_CR49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/diacare.26.1.1","volume":"26","author":"C Levetan","year":"2003","unstructured":"Levetan C, Want L, Weyer C et al (2003) Impact of pramlintide on glucose fluctuations and postprandial glucose, glucagons and triglyceride excursions among patients with type 1 diabetes intensively treated with insulin pumps. Diabetes Care 26:1\u20138","journal-title":"Diabetes Care"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-005-1732-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-005-1732-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-005-1732-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T07:44:40Z","timestamp":1558597480000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-005-1732-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4,21]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["1732"],"URL":"https:\/\/doi.org\/10.1007\/s00125-005-1732-4","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,4,21]]}}}